CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial

Overview of attention for article published in Trials, January 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 396 followers.

CCC publication: CApecitabine Plus Radium-223 (Xofigo™) in Breast Cancer Patients With BONe Metastases (CARBON): Study Protocol for a Phase IB/IIA Randomised Controlled Trial https://t.co/dTZ0FnUx89 #research #healthresearch #openaccess @CCC_Staff

30 Mar 2020

Reply Repost Favourite

CCC publication: CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial. @CCC_Staff https://t.co/dTZ0FnUx89 #research #healthresearch #openaccess

06 Feb 2020

Reply Repost Favourite